Showing results (121-130 of 367) with videos related to

Sort By:
Pageof 37
Journal of Diabetes and Its Complications|August 26, 2023
Changes in cardiac and vascular haemodynamics as potential mediators of improvements in cardiovascular and kidney outcomes with empagliflozin in type 2 diabetesBernhard K Krämer, Sibylle J Hauske, Robert Chilton, et al.
Magnetic Resonance in Medicine|February 22, 2011
Quantitative tracking of edema, hemorrhage, and microvascular obstruction in subacute myocardial infarction in a porcine model by MRINilesh R Ghugre, Venkat Ramanan, Mihaela Pop, et al.
Acta Diabetologica|January 23, 2021
The effects of saxagliptin on cardiac structure and function using cardiac MRI (SCARF)Paul Sandhu, Jann P Ong, Vinay Garg, et al.
The Canadian Journal of Cardiology|June 12, 2022
Dealing With the Epidemic of Endocarditis in People Who Inject DrugsDominique Vervoort, Kevin R An, Malak Elbatarny, et al.
Circulation. Arrhythmia and Electrophysiology|August 28, 2012
Docosahexaenoic acid, but not eicosapentaenoic acid, supplementation reduces vulnerability to atrial fibrillationAndrew Ramadeen, Kim A Connelly, Howard Leong-Poi, et al.
Diabetes Research and Clinical Practice|May 22, 2024
Impact of empagliflozin on first and recurrent events leading to or prolonging hospitalisation in the EMPA-REG OUTCOME trialSilvio E Inzucchi, Christoph Wanner, David Fitchett, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|June 5, 2014
Dipeptidyl peptidase-4 inhibition improves left ventricular function in chronic kidney diseaseKim A Connelly, Bridgit B Bowskill, Suzanne L Advani, et al.
Magnetic Resonance in Medicine|June 2, 2011
Myocardial BOLD imaging at 3 T using quantitative T2: application in a myocardial infarct modelNilesh R Ghugre, Venkat Ramanan, Mihaela Pop, et al.
Pageof 37